View in EDS HTML Full Text PDF Full Text

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).

Saved in:
Bibliographic Details
Title: Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).
Authors: Escribano Subias P; Department of Cardiology, CIBERCV, Instituto de Investigación del Hospital Universitario 12 de Octubre, ERN-LUNG, Universidad Complutense, Madrid, Spain. pilar.escribano.subias@outlook.com., Chakinala MM; Washington University School of Medicine, St. Louis, MO, USA., Chin KM; University of Texas, Southwestern Medical Center, Dallas, TX, USA., Didden EM; Johnson & Johnson, Allschwil, Switzerland., Doad G; Johnson & Johnson, Titusville, NJ, USA., Farber HW; Tufts Medical Center, Boston, MA, USA., Gaine S; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland., Hemnes AR; Vanderbilt University Medical Center, Nashville, TN, USA., Highland KB; Cleveland Clinic, Cleveland, OH, USA., Lange TJ; Department of Pulmonology, Bad Reichenhall Hospital, Bad Reichenhall, Germany.; Department of Internal Medicine II, Faculty of Medicine, Regensburg University, Regensburg, Germany., McLaughlin V; University of Michigan Medical Center, Ann Arbor, MI, USA., Muller A; Johnson & Johnson, Allschwil, Switzerland., Rahman M; Johnson & Johnson, Titusville, NJ, USA., Remeňová T; Johnson & Johnson, Allschwil, Switzerland., Söderberg S; Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden., Venkatesh A; Johnson & Johnson, Allschwil, Switzerland., Kim NH; University of California San Diego, La Jolla, CA, USA.
Source: Drugs - real world outcomes [Drugs Real World Outcomes] 2026 Mar; Vol. 13 (1), pp. 85-100. Date of Electronic Publication: 2026 Jan 12.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing Country of Publication: Switzerland NLM ID: 101658456 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2199-1154 (Print) Linking ISSN: 21989788 NLM ISO Abbreviation: Drugs Real World Outcomes Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41525027
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Escribano+Subias+P%22">Escribano Subias P</searchLink>; Department of Cardiology, CIBERCV, Instituto de Investigación del Hospital Universitario 12 de Octubre, ERN-LUNG, Universidad Complutense, Madrid, Spain. pilar.escribano.subias@outlook.com.<br /><searchLink fieldCode="AU" term="%22Chakinala+MM%22">Chakinala MM</searchLink>; Washington University School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Chin+KM%22">Chin KM</searchLink>; University of Texas, Southwestern Medical Center, Dallas, TX, USA.<br /><searchLink fieldCode="AU" term="%22Didden+EM%22">Didden EM</searchLink>; Johnson & Johnson, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Doad+G%22">Doad G</searchLink>; Johnson & Johnson, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Farber+HW%22">Farber HW</searchLink>; Tufts Medical Center, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gaine+S%22">Gaine S</searchLink>; National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Hemnes+AR%22">Hemnes AR</searchLink>; Vanderbilt University Medical Center, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Highland+KB%22">Highland KB</searchLink>; Cleveland Clinic, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Lange+TJ%22">Lange TJ</searchLink>; Department of Pulmonology, Bad Reichenhall Hospital, Bad Reichenhall, Germany.; Department of Internal Medicine II, Faculty of Medicine, Regensburg University, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22McLaughlin+V%22">McLaughlin V</searchLink>; University of Michigan Medical Center, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Muller+A%22">Muller A</searchLink>; Johnson & Johnson, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rahman+M%22">Rahman M</searchLink>; Johnson & Johnson, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Remeňová+T%22">Remeňová T</searchLink>; Johnson & Johnson, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Söderberg+S%22">Söderberg S</searchLink>; Department of Public Health and Clinical Medicine, Cardiology and Heart Centre, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Venkatesh+A%22">Venkatesh A</searchLink>; Johnson & Johnson, Allschwil, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kim+NH%22">Kim NH</searchLink>; University of California San Diego, La Jolla, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101658456%22">Drugs - real world outcomes</searchLink> [Drugs Real World Outcomes] 2026 Mar; Vol. 13 (1), pp. 85-100. <i>Date of Electronic Publication: </i>2026 Jan 12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+International+Publishing%22">Springer International Publishing </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101658456 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2199-1154 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221989788%22">21989788 </searchLink><i>NLM ISO Abbreviation: </i>Drugs Real World Outcomes <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41525027
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40801-025-00536-4
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 85
    Titles:
      – TitleFull: Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Escribano Subias P
      – PersonEntity:
          Name:
            NameFull: Chakinala MM
      – PersonEntity:
          Name:
            NameFull: Chin KM
      – PersonEntity:
          Name:
            NameFull: Didden EM
      – PersonEntity:
          Name:
            NameFull: Doad G
      – PersonEntity:
          Name:
            NameFull: Farber HW
      – PersonEntity:
          Name:
            NameFull: Gaine S
      – PersonEntity:
          Name:
            NameFull: Hemnes AR
      – PersonEntity:
          Name:
            NameFull: Highland KB
      – PersonEntity:
          Name:
            NameFull: Lange TJ
      – PersonEntity:
          Name:
            NameFull: McLaughlin V
      – PersonEntity:
          Name:
            NameFull: Muller A
      – PersonEntity:
          Name:
            NameFull: Rahman M
      – PersonEntity:
          Name:
            NameFull: Remeňová T
      – PersonEntity:
          Name:
            NameFull: Söderberg S
      – PersonEntity:
          Name:
            NameFull: Venkatesh A
      – PersonEntity:
          Name:
            NameFull: Kim NH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2026 Mar
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2199-1154
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Drugs - real world outcomes
              Type: main
ResultId 1